Marizyme, Inc.
MRZMDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001413754
Marizyme, Inc. was delisted in 2024; its insiders filed their last Form 4 on Dec 28, 2023; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Marizyme, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Marizyme, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Braeden Lichti | 10% Owner | 13,293,841Indirect | Dec 28, 2023 | 0 |
| Dhaduk Vithalbhai D | Chairman of the Board | 4,610,548Indirect | Apr 20, 2023 | 0 |
| Stewart Michael R | Director | – | Jun 9, 2022 | 0 |
| Brostowin Terry A | Director | – | Jun 9, 2022 | 0 |
| Kampf Julie B. | Director | – | Jun 9, 2022 | 0 |
| Patel Nilesh Umedbhai | Director | – | Jun 9, 2022 | 0 |
| Hearl William | Director | – | Jun 9, 2022 | 0 |
| Ross Harrison | Vice President of Finance | – | Mar 21, 2022 | 0 |
| Kovalyov Georgiy | Chief Financial Officer | – | Mar 18, 2022 | 0 |
| Barthel David | Chief Executive Officer | – | Feb 9, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 (view filing)10:22 AM ET | Jun 29-Aug 29 | 71 days | Braeden Lichti10% Owner | SSale | −308.3K | $0.1187 | −$36.6K | −3.2%9.48M after | Amended3 lots |